To date, genome-wide association studies have implicated at least 35 loci in osteoarthritis, but 18 due to linkage disequilibrium, we have yet to pinpoint the specific variants that underlie these 19 associations, nor the mechanisms by which they contribute to disease risk. Here we functionally 20 tested 1,605 single nucleotide variants associated with osteoarthritis for regulatory activity using 21 a massively parallel reporter assay. We identified six single nucleotide polymorphisms (SNPs) 22 with differential regulatory activity between the major and minor alleles. We show that our most 23 significant hit, rs4730222, drives increased expression of an alternative isoform of HBP1 in a 24 heterozygote chondrosarcoma cell line, a CRISPR-edited osteosarcoma cell line, and in 25 chondrocytes derived from osteoarthritis patients. 26 27 Main text 28 29 Genome-wide association studies (GWAS) have successfully implicated thousands of genetic 30 loci in common human diseases. Most of the underlying signal is believed to derive from 31 variation in non-coding regulatory sequences. However, because of linkage disequilibrium (LD), 32 it has been extraordinarily challenging for the field to identify the variants that causally underlie 33 each association.
alternative isoform in SW1353 cells, which are likely heterozygous for the entire OA-associated 140 haplotype, could be consequent to any or several of these SNPs, or to other forms of genetic 141 variation. To test whether rs4730222 causally underlies the allelic imbalance of the HBP1 142 alternative transcript, we introduced the minor allele of rs4730222 into Saos-2 cells, which are 143 homozygous for the major allele, through CRISPR-mediated homology directed repair (HDR). 144 We generated four biological replicates (i.e. independently edited cell populations), and 145 quantified the RNA-DNA ratio of indel-free reads derived from the major vs. minor allele. 146 Similar to the SW1353 AEI (1.3 to 1.4-fold), we identified a 1.4 to 1.6-fold relative enrichment 147 in the RNA/DNA ratio for the minor allele compared to the major allele (Fisher's exact test, 148 p<1e-5; Fig. 2C ). This confirms that the minor allele at rs4730222 causally underlies 149 upregulation of the HBP1 alternative isoform.
151
We next sought to test whether rs4730222 drives increased transcription of the alternative TSS in 152 osteoarthritic tissue. To do so, we tested for AEI in chondrocytes derived from OA patients. For 153 each of nine patients heterozygous for rs4730222, we extracted RNA and DNA and amplified 154 and sequenced the 5'UTR containing the SNP (three technical replicates per patient) from DNA 155 and cDNA. Despite low cDNA concentrations and low expression of the alternative TSS, we 156 observed an overall trend in AEI in accordance with our reporter assay and cell models (median 157 AEI=1.12, Mann Whitney U-test on 27 DNA ratios vs. 27 RNA ratios, p=0.003). Interestingly, 158 one patient appeared to exhibit AEI in the opposite direction 35, 36 (Supplementary Fig. 3) . 159 160 5 In summary, we set out to functionally test the regulatory effects of 1,605 SNPs that potentially 161 underlie 35 GWAS signals for osteoarthritis. We succeeded in generating reproducible 162 measurements of regulatory activity for about two-thirds of the regions tested, and of differential 163 regulatory activity for about half of the regions tested. The most highly active regions in our 164 assay were ~2-fold enriched for biochemical marks associated with enhancers. We furthermore 165 identified six SNPs, which each drove differential expression at an FDR of 5%. The most 166 significant of these, rs4730222, resides in the 5' UTR of multiple isoforms of HBP1, a 167 transcriptional repressor. The minor, OA-associated risk allele of rs4730222 increases 168 transcription of alternative isoform(s) of HBP1. We validated this finding in SW1353 cells,
169
CRISPR-edited Saos2 cells, and in chondrocytes derived from knee OA patients.
171
We previously described reduced expression of the canonical HBP1 transcript in OA tissue, 172 relative to healthy tissue 29 . Here, we do not observe AEI of the canonical HBP1 transcript, but 173 rather AEI of an alternative transcript. We speculate that the impact of rs4730222, wherein the 174 disease-associated allele consistently increases expression of an alternative transcript, 175 secondarily reduces expression of canonical HBP1. One possibility is that the alternative isoform 176 encodes a non-coding RNA with an upstream open reading frame (uORF). This isoform of 177 HBP1 may have a trans effect on the canonical transcript, or have its own, yet uncharacterized, 178 function in the cell. Additionally, alternative TSSs have been shown to modulate translational 179 efficiency and tissue specificity of genes 37,38 . Through one or several of these mechanisms, the 180 expression levels of this isoform might modulate HBP1 levels in certain tissues. Finally, we note 181 that the rs4730222-overlapping isoform expressed in SW1353 and Saos2 is a truncated version 182 of HBP1. Therefore, it may disrupt endogenous activity of the gene, e.g. by acting as a in the mRNA and DNA population through sequencing. G). For each allele, we calculated one 219 activity score as the average log2(RNA/DNA) across all independent measurements. We 220 identified six SNPs with significantly different activity between the major and minor alleles. 
Supplementary Table 1 Identification and design of target SNPs 293 We selected SNPs that had a minor allele frequency >5% and had been reported as being 294 associated with OA in European populations at a significance level that surpassed or approached 295 the genome-wide threshold of <5e-8. The deadline date for inclusion was May 2017. In total, 35 296 SNPs were identified, each representing an independent association signal (Table S1 ). We ran 355 We aligned all sequencing reads to a reference fasta file of our variants using BWA mem and 356 extracted reads from error-free molecules 39 We then performed a Benjamini-Hochberg correction with an FDR = 0.05 to correct for multiple 369 testing. Allelic Imbalance of rs4730222 in SW1353 cells 372 We first genotyped several osteogenic and chondrogenic cell lines for rs4730222 (SW1353,   373 Tc28a/2, Saos-2, chondrogenic progenitor cells) using rs4730222_sangerF (5'-374 TACGCAGTTCGAATGAATGGGCTC -3') and rs4730222_sangerR (5'-375 AGCTACAAAAACCTGGCTGTCCAC -3'). PCR products were purified with a 1.5x AMPure 376 cleanup and Sanger sequenced with rs4730222_sangerF. 377 We then tested for allelic imbalance of rs4730222 in the isoforms expressing the SNP in 378 SW1353. We performed three independent DNA and RNA extractions using the Qiagen 3'). We therefore designed a guideRNA that would target rs4730222, so that the minor-allele 396 donor would not be re-cut. We ordered the following oligos from IDT: rs4730222_guideF (5'-397 CACCGACGCGATGAATGGCGAAAGA -3') and rs4730222_guideR (5'-398 AAACTCTTTCGCCATTCATCGCGTC -3') and followed the Zhang lab protocol to clone them 399 into the px458 plasmid (SpCas9-2A-EGFP and single guide RNA). 400 We created our donor vector in two steps. First, we amplified a 1,459 bp region around 401 rs4730222 with the following primers, which also append 16 bp homologous sequence to puc19 CTCCTCAACCGAAACTTTCCTACTT -3'). We also amplified a small region around 411 rs4730222, while mutating the SNP, using mut_insF (5'-412 AAGTAGGAAAGTTTCGGTTGAGGAG -3') and mut_insR (5'-413 CCAAGTCCATCCCCCACGCTCTTTCGCCATTCATCGCG -3'). We then cloned the mutated 414 insert into puc19-HBP1-wt using the In-Fusion HD Cloning Kit and grew up a single colony 415 with the minor allele at rs4730222 flanked by 600-850 bp of homology on each side. 416 We transfected 1 million Saos-2 cells with 10 ug of our px458-rs4730222 guide and 10 ug of our 417 donor library containing the minor allele using the Neon Transfection system as described above. Characterization of HBP1 rs4730222-containing isoforms 459 We designed the following set of primers to differentiate between different HBP1 isoforms: 
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